Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: Medtech Mitral Tricuspid Valve and LAAO Regulatory Science Town Hall [Non-CME]

Panel Discussion | The Direction of Future of Studies of Tricuspid Valve Interventions

Monday, March 9, 2026
2:30 PM - 3:00 PM EST
Location: International Ballroom West

    Moderator(s)

  • Changfu Wu, PhD

    SBRBPAS Expert
    Food and Drug Administration
    Silver Spring, Maryland, United States

    Disclosure(s): No financial relationships to disclose

    • Panel Discussant(s)

  • Suzanne V. Arnold, MD

    Professor
    Saint Luke's Mid America Heart Institute
    Kansas City, Missouri, United States

    Disclosure(s): No financial relationships to disclose

  • Steven F. Bolling, MD

    Professor of Cardiac Surgery
    University of Michigan Hospital
    Ann Arbor, Michigan, United States

    Disclosure information not submitted.

  • Rebecca T. Hahn, MD

    Director of Interventional Echocardiography
    Columbia University/NewYork-Presbyterian Hospital
    New York, New York, United States

    Disclosure(s): Abbott Vascular,: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Phillips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Jim Mayberry

    SVP, Global Therapy Leader, Transcatheter Tricuspid Valve Replacement
    Edwards Lifesciences

    Disclosure(s): Edwards Lifesciences: Employee (Ongoing)

  • Megan Naber

    Lead Reviewer
    FDA

    Disclosure(s): No financial relationships to disclose

  • VP

    Vinny Podichetty

    Disclosure information not submitted.

  • Maurice Sarano, MD

    Senior Scientist
    Minneapolis Heart Institute
    Minneapolis, Minnesota, United States

    Disclosure(s): HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Bill Shields, MBA

    Vice President & General Manager
    Medtronic
    Mounds View, Minnesota, United States

    Disclosure(s): Medtronic: Employee (Ongoing)

  • Lars Sondergaard, MD

    Chief Medical Officer
    Abbott Structural Heart
    Santa Clara, California, United States

    Disclosure(s): Abbott: Employee (Ongoing)

  • Kevin G. Soucy, PhD

    Principal Consultant
    CardioMed Device Consultants, LLC, United States

    Disclosure(s): Many cardiovascular device manufacturers: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Samuel Raben, PhD

    Team Lead with the Heart Valve Devices Team
    FDA

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Changfu Wu, PhD: No financial relationships to disclose
Suzanne V. Arnold, MD: No financial relationships to disclose
Rebecca T. Hahn, MD: Abbott Vascular,: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Phillips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jim Mayberry: Edwards Lifesciences: Employee (Ongoing)
Megan Naber: No financial relationships to disclose
Maurice Sarano, MD: HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)
Bill Shields, MBA: Medtronic: Employee (Ongoing)
Lars Sondergaard, MD: Abbott: Employee (Ongoing)
Kevin G. Soucy, PhD: Many cardiovascular device manufacturers: Consulting Fees (e.g., advisory boards) (Ongoing)
Samuel Raben, PhD: No financial relationships to disclose